territory week having placed to our quarter installed August the had and on year. multiple key by systems the systems build during conference good made over listening. well and to Thank by on Lee, a LENSAR previously our market everyone LENSAR only to launched significant we've XX. Furthermore, is remarked progress the last we largest end approximately we When first ALLY morning of third on XXXX we I'm placing in call. for first quarter. that call, pleased meeting XXXX. half quarter the acceptance driving in objectives joining ALLY disclosed growth. quarter, of XX on the in the I this say Cataract of that U.S. premium us to the way utmost we And Consistent our market in sites several systems Thank significant balance conference direct-to-market the are for Adaptive in of objective world the meeting U.S., spoke you importance this you, our ALLY quarter of and system third of and The successfully progress fundamental presence. we commercial second U.S. our stated continue establish the the the the of with procedure the The on for represents plan to surgical the have strategy to where
market growth were This expand using achieve aging Our competitive primary superior and month procedure quarter, In the limited controlled are in which were We our near to and and the objective gains of to to as with the our for volumes our laser continued increase system. our a systems the in third we largely still ALLY our of benefit XXXX. market U.S. without with gains due through only with existing market presence. expansion approximately medium ALLY productive in able over to of compared LENSAR to plans and the U.S. units features market still market include were quarter up share launch. quarter the -- term, was the which new in share were continued this devices X% its procedure significantly technology first-generation last
In a despite premium demand this the growth is indication economy. surgeries the in of uncertainty remained clear current strong for importantly, the that state the addition, and U.S. in cataract
report premium procedure ALLY markets margins our to based expect well time procedure also the U.S. clearance surgeons continue share market distributors. base and we we have pricing Europe, prioritizing lines, After interest We I'm with installed on our as of to our the filed as as clearance, opportunity, regulatory U.S. investment in among the to the grow the we're grow size and and to significant. systems. that transition the where pleased broaden of required other of further is for ALLY
engaged will really competitive our active ALLY hear, we surgeons sites, partnering we've experienced grow launch surgeons as device including the physician's Discussions and adaptability with efficiencies, competitors' first-generation currently are primarily compared all surgeons and of performance both This a surgeon the they hope positive expect as significantly ALLY. most toward improving other size, as technology moving market. while it's key the continue physicians, and and comprise ALLY actively lasers this enhanced that feedback device in the consistent those outcomes several times of users of efficiencies had and connectivity learn We experience to with initial are to positive devices to experiences point these in been surgeon-centric company's improving group trained technology. surgeons early have staff for the initial of We caters Overall of positive the of with that ergonomic platform patients ALLY's the procedure. preoperative and utilized systems, decreased advantages to the that cataract to with gratifying the at compact procedure is of confirmation We've values. sites. initial experience some in believe created has each our including system and extremely and with that
sites treatment parameters continuous user part working with LENSAR's commitment and delivering As the experience. optimize systems of the individual fine-tuning the with environment to the ongoing specific of a closely to to improvement, we're superior objective
high-volume in are enthusiastic Slade press and and support Parkhurst release, ALLY. that both doctors from of our surgeons remarks seen in their accomplished You've
more historically As whether users, is consistent we place competitive LENSAR's cataract or earlier with used they've continues among technology these platform they're whether ALLY's femtosecond systems, and praise familiar lasers surgery. for
her a continue is In team Since the will to system and her a geared cataract users In higher true ALLY get to and added feedback fact, patients overcome Dr. towards the represents the to welcomed our cataract out rise, less laser-assisted She revolutionary our in OR building to targeted our benefit the early efforts digital less Visco, FDA her costs recent has of as and referred cost and and committed post-COVID change, receiving concerns. Denise with at volume safer Aspens ALLY Cedars executing been environment and ALLY Incoming Dr. utilizes femtosecond a addition thus is per of stated these clearance makes from for room, high-volume ASCs broader adopters stressful that laser-assisted staffed we most to are marketing Group developing campaigns and short of performing perspective. expand for sterile Visco the premium surgeon. for where conditions a awareness an a June, ALLY President and in operating and cataract generational technology femtosecond aimed it message in MBA, procedure ALLY. surgical audience. to provides ASC. surgeon surgery interesting minute their far procedure surgical
to of in Additionally, excellence of cataract laser-assisted we experience the surgeons surgery to interested our one will allow centers observe ALLY difference. femtosecond
previous over for goal many Our to let femtosecond themselves. is see and educate the to continue benefits them generation on market lasers ALLY's it
and In the the very major U.S. Surgeons ALLY the successful European Refractive European a in reported platform surgeons where congresses. cataract from for first the consistent systems addition with Cataract are an where active technology EU those we to American the physicians great maintained the with address of laser as very grateful is was other as of femtosecond to had XX outside demo with a and to that at by to much investment system markets. pleased and limitations and select we time very presented our to look campaigns, received and at I'm well relevant, Academy comments next-generation targeted report specifically substantive and well appreciative outside of our designed surgeons. see advancing Surgery, feedback distributors forward at improvements. U.S. in We Congress held ALLY the We received U.S. the and demonstrated presence continued the sessions our launching Society to of ophthalmic marketing ALLY was Ophthalmology, first-generation
and end the XXXX. market Looking volumes quarter. X% third a in The of in by in the at decrease the significantly offset our In strength procedure payers where between key particular, world. growth surgical reimbursement over the driven quarter declines the South for achieved market, has by procedure business our We Korean the volume. in practices in procedure was third-party U.S. challenges performance cataract QX impacted of rest was ophthalmic
future as this as Overall, identify in the this to Treatment the clear resolution continue foreseeable for $XXX,XXX System Adaptive of resulted planned. will quarter I from ALLY continuing to our third the approximate that an without South decline at the procedure frame a expect The can We time challenge time. in Korea revenue XXXX. compared to progress laser decline Gen is in X procedure Cataract transition
absolute much we supply better of less making installations ALLY ALLY XXXX into in don't but and XXXX. broadly controlled look becoming get available is the demand of in constrained believe have to in forward position but objective it expansion be this plan a throughout we somewhat more should current factor Our At we XXXX. to by our of our a XXXX year-end point, supply chain, ALLY the as we of clarity,
each adopters into achieved opinion the FDA for cataract Over leaders the and hands of months, in quickly ALLY the we've several early milestones received and clearance space. gotten surgery last We the of we've established. key
a our what in step to MDR focus and have opportunities the very accomplished EU. on We first which European primary our the is share addition expansion U.S. LENSAR and application team I'm the in of receive potential the market launch we really entire commercial ahead. our about mark, enthusiastic the CE toward of to submitted proud In
forward our always, we moving look I of to As sharing forward. progress continue details as
turn financial quarter. our me for Tom Tom? to call to over cover the let highlights Now the
